Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype

16Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Germline mutations in GATA2 are associated with a complex immunodeficiency and cancer predisposition syndrome. Somatic GATA2mut in myeloid malignancies may impart a similar phenotype. We reviewed adult patients with a diagnosis of GATA2mut hematological malignancy who were referred to our HHMC for genetic testing, and identified to have somatic GATA2mut. Nine patients with a median age of 63 years were included. Six patients (66.7%) were males. Atypical CML and acute myeloid leukemia were the most common initial presentation. The median overall VAF was 47.14%. Monocytopenia was pronounced when the GATA2mut involved the C-terminal ZFD. GATA2 N-terminal ZFD mutations tend to be co-mutated with biCEBPAmut. Unlike germline GATA2 mutations, monocytopenia associated with somatic GATA2 mutations often resolved at remission. We concluded that similar to germline GATA2 mutations, a subset of somatic GATA2 mutations can impart a germline phenotype.

Cite

CITATION STYLE

APA

Alfayez, M., Wang, S. A., Bannon, S. A., Kontoyiannis, D. P., Kornblau, S. M., Orange, J. S., … DiNardo, C. D. (2019). Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype. Leukemia and Lymphoma, 60(8), 2025–2033. https://doi.org/10.1080/10428194.2018.1551535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free